Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

NCT00812955 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

Interventions

DRUG: ABT-143
DRUG: simvastatin

Sponsor

AstraZeneca